AI Medical Compendium Journal:
Molecular diversity

Showing 61 to 70 of 70 articles

Artificial intelligence to deep learning: machine intelligence approach for drug discovery.

Molecular diversity
Drug designing and development is an important area of research for pharmaceutical companies and chemical scientists. However, low efficacy, off-target delivery, time consumption, and high cost impose a hurdle and challenges that impact drug design a...

A novel artificial intelligence protocol to investigate potential leads for diabetes mellitus.

Molecular diversity
Dipeptidyl peptidase-4 (DPP4) is highly participated in regulating diabetes mellitus (DM), and inhibitors of DPP4 may act as potential DM drugs. Therefore, we performed a novel artificial intelligence (AI) protocol to screen and validate the potentia...

In silico design of novel aptamers utilizing a hybrid method of machine learning and genetic algorithm.

Molecular diversity
Aptamers can be regarded as efficient substitutes for monoclonal antibodies in many diagnostic and therapeutic applications. Due to the tedious and prohibitive nature of SELEX (systematic evolution of ligands by exponential enrichment), the in silico...

Classification models and SAR analysis on CysLT1 receptor antagonists using machine learning algorithms.

Molecular diversity
Cysteinyl leukotrienes 1 (CysLT1) receptor is a promising drug target for rhinitis or other allergic diseases. In our study, we built classification models to predict bioactivities of CysLT1 receptor antagonists. We built a dataset with 503 CysLT1 re...

A multimodal deep learning-based drug repurposing approach for treatment of COVID-19.

Molecular diversity
Recently, various computational methods have been proposed to find new therapeutic applications of the existing drugs. The Multimodal Restricted Boltzmann Machine approach (MM-RBM), which has the capability to connect the information about the multip...

Distinguishing drug/non-drug-like small molecules in drug discovery using deep belief network.

Molecular diversity
The advent of computational methods for efficient prediction of the druglikeness of small molecules and their ever-burgeoning applications in the fields of medicinal chemistry and drug industries have been a profound scientific development, since onl...

Pharmacophore features for machine learning in pharmaceutical virtual screening.

Molecular diversity
Methods of three-dimensional molecular alignment generally treat all pharmacophore features equally when superimposing. However, some pharmacophore features can be more important in a specific system. In this work, we derived the overlap volume of ph...

Classification of thyroid hormone receptor agonists and antagonists using statistical learning approaches.

Molecular diversity
In silico models are presented for modeling and predicting thyroid hormone receptor (TR) agonists and antagonists. A data set consisting of 258 compounds is used in the present work. The C4.5, random forest (RF) and support vector machine (SVM) stati...

Practical application of the Average Information Content Maximization (AIC-MAX) algorithm: selection of the most important structural features for serotonin receptor ligands.

Molecular diversity
The Average Information Content Maximization algorithm (AIC-MAX) based on mutual information maximization was recently introduced to select the most discriminatory features. Here, this methodology was applied to select the most significant bits from ...

Discovery of Influenza A virus neuraminidase inhibitors using support vector machine and Naïve Bayesian models.

Molecular diversity
Neuraminidase (NA) is a critical enzyme in the life cycle of influenza virus, which is known as a successful paradigm in the design of anti-influenza agents. However, to date there are no classification models for the virtual screening of NA inhibito...